Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Google Scholar
Cancer Registry Annual Report, 2015, Taiwan. Health promotion administration, Ministry of Health and Welfare 2017. https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=269&pid=13498.
Reck M, Heigener DF, Mok T, Soria JC, Rabe KF. Management of non-small-cell lung cancer: recent developments. Lancet. 2013;382:709–19.
Article
CAS
Google Scholar
Reck M, Rabe KF. Precision diagnosis and treatment for advanced non-small-cell lung cancer. N Engl J Med. 2017;377(9):849–61.
Article
CAS
Google Scholar
Antoszczak M, Markowska A, Markowska J, Huczyński A. Old wine in new bottles: drug repurposing in oncology. Eur J Pharmacol. 2020;866:1727–84.
Article
Google Scholar
Elwood PC, Gallagher AM, Duthie GG, Mur LA, Morgan G. Aspirin, salicylates, and cancer. Lancet. 2009;373(9671):1301–9.
Article
CAS
Google Scholar
Thun MJ, Jacobs EJ, Patrono C. The role of aspirin in cancer prevention. Nat Rev Clin Oncol. 2012;9(5):259–67.
Article
CAS
Google Scholar
Chubak J, Whitlock EP, Williams SB, Kamineni A, Burda BU, Buist DS, et al. Aspirin for the prevention of cancer incidence and mortality: systematic evidence reviews for the U.S. preventive services task force. Ann Intern Med. 2016;164(12):814–25.
Article
Google Scholar
Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne colorectal Cancer study. Cancer Res. 1988;48(15):4399–404.
CAS
PubMed
Google Scholar
Tsoi KK, Ho JM, Chan FC, Sung JJ. Long-term use of low-dose aspirin for cancer prevention: a 10-year population cohort study in Hong Kong. Int J Cancer. 2019;145(1):267–73.
Article
CAS
Google Scholar
Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. Low-dose aspirin in the primary prevention of cancer: the Women’s health study: a randomised controlled trial. JAMA. 2005;294(1):47–55.
Article
CAS
Google Scholar
Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst. 1993;85(15):1220–4.
Article
CAS
Google Scholar
Burn J, Bishop DT, Mecklin JP, Macrae F, Möslein G, Olschwang S, et al. Effect of aspirin on resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med. 2008;359(24):2567-78
McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, et al. ASPREE Investigator Group. Effect of aspirin on all-cause mortality in the healthy elderly. N Engl J Med. 2018;379(16):1519–28
Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E. Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res. 2004;24(5B):3177–84.
Fontaine
E, McShane J, Page R, Shackcloth M, Mediratta N, Carr M, et al. Aspirin and
non-small cell lung cancer resections: effect on long-term survival. Eur J Cardiothorac Surg. 2010;38(1):21–6.
Brasky TM, Baik CS, Slatore CG, Alvarado M, White E. Pre-diagnostic nonsteroidal anti-inflammatory drug use and cancer survival in the VITAL study. J Thorac Oncol. 2012;7(10):1503–12.
Article
CAS
Google Scholar
Wang H, Liao Z, Zhuang Y, Liu Y, Levy LB, Xu T, et al. Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapy. Clin Lung Cancer. 2015;16(2):128–36.
McMenamin ÚC, Cardwell CR, Hughes CM, Murray LM. Low-dose aspirin and survival from lung cancer: a population-based cohort study. BMC Cancer. 2015;15:911.
Veitonmäki T, Murtola TJ, Talala K, Taari K, Tammela T, Auvinen A. Non-steroidal anti-inflammatory drugs and cancer death in the finnish prostate cancer screening trial. PLoS One. 2016;11(4):e0153413.
Maddison P. Effects of aspirin on small-cell lung cancer mortality and metastatic presentation. Lung Cancer. 2017;106:67–9.
Article
Google Scholar
Kang J, Jeong SM, Shin DW, Cho M, Cho JH, Kim J. The associations of aspirin, statins, and metformin with lung cancer risk and related mortality: time-dependent analysis of population-based nationally representative data. J Thorac Oncol. 2021;16(1):76–88.
Article
CAS
Google Scholar
Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(10):236–42.
Article
Google Scholar
Kao WH, Hong JH, See LC, Yu HP, Hsu JT, Chou IJ, et al. Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan. Pharmacoepidemiol Drug Saf. 2018;27(10):1060–6.
Article
Google Scholar
Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Yang YH, et al. Taiwan’s national health insurance research database: past and future. Clin Epidemiol. 2019;11:349–58.
Article
Google Scholar
Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, et al. Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection. JAMA. 2012;308(18):1906–14.
Article
CAS
Google Scholar
Cho IS, Chae YR, Kim JH, Yoo HR, Jang SY, Kim GR, et al. Statistical methods for elimination of guarantee- time bias in cohort studies: a simulation study BMC Med Res Methodol. 2017;17(1):126.
PubMed
Google Scholar
Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nat New Biol. 1971;231(25):232–5.
Article
CAS
Google Scholar
Craven LL. Acetylsalicylic acid: possible preventive of coronary thrombosis. Ann West Med Surg. 1950;4(2):95–9.
CAS
PubMed
Google Scholar
Gann PH, Manson JE, Glyn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomised trial. J Natl Cancer Inst. 1993;85:1220–4.
Article
CAS
Google Scholar
Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, et al. Randomised trial of prophylactic daily aspirin in British male doctors. BMJ. 1988;296:313–6.
Article
CAS
Google Scholar
Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302(6):649–58.
Article
CAS
Google Scholar
Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20 year follow-up of five randomised trials. Lancet. 2010; 376(9754):1741–50
Bonifazi M, Gallus S, Bosetti C, Polesel J, Serraino D, Talamini R, et al. Aspirin use and pancreatic cancer risk. Euro J Cancer Prevent. 2010;19(5):352–4.
Article
CAS
Google Scholar
Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol. 2010;28(9):1467–72.
Article
CAS
Google Scholar
Choe KS, Cowan JE, Chan JM, Carroll PR, D’Amico AV, Liauw SL. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol. 2012;30(28):3540–4.
Article
CAS
Google Scholar
Elwood PC, Morgan G, Pickering JE, Galante J, Weightman AL, Morris D, el al. Aspirin in the treatment of cancer: reductions in metastatic spread and in mortality: A systematic review and meta-analyses of published studies. PLoS One. 2016;11(4):e0152402.
Elwood PC, Pickering JE, Morgan G, Galante J, Weightman AL, et al. Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients? PLoS One. 2018;13(9):e0203957.
Hochmuth F, Jochem M, Schlattmann P. Meta-analysis of aspirin use and risk of lung cancer shows notable results. Eur J Cancer Prev. 2016;25(4):259–68.
Article
CAS
Google Scholar
Ogawa F, Amano H, Ito Y, Matsui Y, Hosono K, Kitasato H, et al. Aspirin reduces lung cancer metastasis to regional lymph nodes. Biomed Pharmacother. 2014;68(1):79–86.
Article
CAS
Google Scholar
Rothwell PM, Fowkes FGR, Belch JFF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377(9759):31–41.
Article
CAS
Google Scholar
Gasic GJ, Gasic TB, Stewart CC. Anti-metastatic effects associated with platelet reduction. Proc Natl Acad Sci USA. 1968;61(1):46–52.
Gasic GJ, Gasic TB, Murphy S. Anti-metastatic effect of aspirin. Lancet. 1972;2(7783):932–3.
Article
CAS
Google Scholar
Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 2007;356(21):2131–42.
Article
CAS
Google Scholar
Khuder SA, Herial NA, Mutgi AB, Federman DJ. Nonsteroidal anti-inflammatory drug use and lung cancer: A metaanalysis. Chest. 2005;127(3):748–54.
Article
Google Scholar
Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene. 2004;23(57):9247–58.
Article
CAS
Google Scholar
Bellosillo B, Piqué M, Barragán M, Castaño E, Villamor N, Colomer D, et al. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukaemia cells. Blood. 1998;92(4):1406–414.
Kashfi K, Rigas B. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention. Biochem Pharmacol. 2005;70(7):969–86.
Article
CAS
Google Scholar
Maity G, Chakraborty J, Ghosh A, Haque I, Banerjee S, Banerjee SK. Aspirin suppresses tumor cell-induced angiogenesis and their incongruity. J Cell Commun Signal. 2019;13(4):491–502.
Article
Google Scholar
Ma WY, Huang C, Dong Z. Inhibition of ultraviolet C irradiation-induced AP-1 activity by aspirin is through inhibition of JNKs but not erks or P38 MAP kinase. Int J Oncol. 1998;12(3):565–8.
CAS
PubMed
Google Scholar